- Home
- TRSG vs DXR Comparison
TRSG vs DXR Comparison
Compare TRSG & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- DXR
- Stock Information
- Founded
- TRSG 1996
- DXR 1970
- Country
- TRSG Singapore
- DXR United States
- Employees
- TRSG N/A
- DXR N/A
- Industry
- TRSG
- DXR Medical/Dental Instruments
- Sector
- TRSG
- DXR Health Care
- Exchange
- TRSG NYSE
- DXR Nasdaq
- Market Cap
- TRSG 33.4M
- DXR 37.6M
- IPO Year
- TRSG 2024
- DXR N/A
- Fundamental
- Price
- TRSG $1.91
- DXR $7.24
- Analyst Decision
- TRSG
- DXR Strong Buy
- Analyst Count
- TRSG 0
- DXR 1
- Target Price
- TRSG N/A
- DXR $24.75
- AVG Volume (30 Days)
- TRSG 2.9K
- DXR 5.7K
- Earning Date
- TRSG 12-31-2024
- DXR 01-01-0001
- Dividend Yield
- TRSG N/A
- DXR N/A
- EPS Growth
- TRSG N/A
- DXR N/A
- EPS
- TRSG N/A
- DXR 0.35
- Revenue
- TRSG $14,441,864.00
- DXR $154,205.00
- Revenue This Year
- TRSG N/A
- DXR N/A
- Revenue Next Year
- TRSG N/A
- DXR N/A
- P/E Ratio
- TRSG N/A
- DXR $20.78
- Revenue Growth
- TRSG 9.34
- DXR N/A
- 52 Week Low
- TRSG $1.91
- DXR $6.55
- 52 Week High
- TRSG $11.78
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- DXR 37.76
- Support Level
- TRSG N/A
- DXR $7.00
- Resistance Level
- TRSG N/A
- DXR $7.49
- Average True Range (ATR)
- TRSG 0.00
- DXR 0.33
- MACD
- TRSG 0.00
- DXR -0.01
- Stochastic Oscillator
- TRSG 0.00
- DXR 44.44
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.